Stock Research for GBLX

GBLX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GBLX Stock Chart & Research Data

The GBLX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GBLX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GBLX Due diligence Resources & Stock Charts

The GBLX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GBLX Detailed Price Forecast - CNN Money CNN View GBLX Detailed Summary - Google Finance
Yahoo View GBLX Detailed Summary - Yahoo! Finance Zacks View GBLX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GBLX Trends & Analysis - Trade-Ideas Barrons View GBLX Major Holders - Barrons
NASDAQ View GBLX Call Transcripts - NASDAQ Seeking View GBLX Breaking News & Analysis - Seeking Alpha
Spotlight View GBLX Annual Report - CompanySpotlight.com OTC Report View GBLX OTC Short Report - OTCShortReport.com
TradeKing View GBLX Fundamentals - TradeKing Charts View GBLX SEC Filings - Bar Chart
WSJ View Historical Prices for GBLX - The WSJ Morningstar View Performance/Total Return for GBLX - Morningstar
MarketWatch View the Analyst Estimates for GBLX - MarketWatch CNBC View the Earnings History for GBLX - CNBC
StockMarketWatch View the GBLX Earnings - StockMarketWatch MacroAxis View GBLX Buy or Sell Recommendations - MacroAxis
Bullish View the GBLX Bullish Patterns - American Bulls Short Pains View GBLX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GBLX Stock Mentions - StockTwits PennyStocks View GBLX Stock Mentions - PennyStockTweets
Twitter View GBLX Stock Mentions - Twitter Invest Hub View GBLX Investment Forum News - Investor Hub
Yahoo View GBLX Stock Mentions - Yahoo! Message Board Seeking Alpha View GBLX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GBLX - SECform4.com Insider Cow View Insider Transactions for GBLX - Insider Cow
CNBC View GBLX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GBLX - OTC Markets
Yahoo View Insider Transactions for GBLX - Yahoo! Finance NASDAQ View Institutional Holdings for GBLX - NASDAQ


Stock Charts

FinViz View GBLX Stock Insight & Charts - FinViz.com StockCharts View GBLX Investment Charts - StockCharts.com
BarChart View GBLX Stock Overview & Charts - BarChart Trading View View GBLX User Generated Charts - Trading View




Latest Financial News for GBLX


GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine
Posted on Wednesday October 09, 2019

LAS VEGAS , Oct. 9, 2019 /CNW/ -- GB Sciences, Inc. (GBLX) is featured in the October 2019 edition of the Marijuana Business Magazine. Dr. Andrea Small-Howard , GB Sciences' Chief Science Officer and Director, explains why GB Sciences is well-positioned to provide research-supported product formulations for both market segments.


GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation
Posted on Tuesday September 17, 2019

LAS VEGAS, Sept. 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX), on Friday, September 13, 2019, filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana, LLC.  The stake will be purchased by Wellcana Plus LLC, affiliated through its managers with the group which holds the other 50% of the Louisiana operations.  Expected to close by the end of October 2019, the sale is for $16 million to GB Sciences, $7 million in cash at closing, $1 million in cash within 60 days of closing, and the remaining $8 million as an earn out.  The actual proceeds realized through the earn out and the timing of those proceeds will depend upon the profitability of the Louisiana operations. The sale will greatly reduce the current and future burn rate of the Company and allow it to focus on achieving profitability, seeking a DEA license, and implementing GMP, a set of regulations promulgated by the US Food and Drug Administration to ensure quality control in the manufacture of pharmaceuticals, dietary supplements and natural health products among other substances, at its Las Vegas, Nevada location.


U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers
Posted on Tuesday September 03, 2019

U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers


GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations
Posted on Wednesday August 28, 2019

LAS VEGAS , Aug. 28, 2019 /CNW/ -- GB Sciences, Inc. (GBLX) today announced the appointment to GB Sciences' executive team of Darin Carpenter as the company's new Executive Vice President for Operations and General Manager, bringing his extensive and nationally-recognized experience streamlining production, improving product quality, and increasing profitability to GBS.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.